Skip to main content
padlock icon - secure page this page is secure

Open Access VirtualToxLabin silico Prediction of the Endocrine-Disrupting Potential of Drugs and Chemicals

Download Article:
(PDF 1,088.6 kb)
In the last decade, we have developed and validated an in silico concept based on multidimensional QSAR (mQSAR) for the prediction of the toxic potential of drugs and environmental chemicals. Presently, the VirtualToxLab includes eleven so-called virtual test kits for estrogen (α/β), androgen, thyroid (α/β), glucocorticoid, aryl hydrocarbon, mineralocorticoid and peroxisome proliferator-activated receptor γ as well as for the enzymes cytochrome P450 3A4 and 2A13. The surrogates have been tested against a total of 824 compounds and are able to predict the binding affinity close to the experimental uncertainty with only six of the 194 test compounds giving calculated results more than a factor of 10 off the experimental binding affinity and the maximal individual deviation not exceeding a factor of 15. These results suggest that our approach is suited for the in silico identification of endocrine-disrupting effects triggered by drugs and environmental chemicals. Most recently, the technology has been made available through the Internet for academic laboratories, hospitals and environmental organizations.

24 References.

No Supplementary Data.
No Article Media
No Metrics


Document Type: Research Article

Publication date: May 1, 2008

More about this publication?
  • International Journal for Chemistry and Official Membership Journal of the Swiss Chemical Society (SCS) and its Divisions

    CHIMIA, a scientific journal for chemistry in the broadest sense, is published 10 times a year and covers the interests of a wide and diverse readership. Contributions from all fields of chemistry and related areas are considered for publication in the form of Review Articles and Notes. A characteristic feature of CHIMIA are the thematic issues, each devoted to an area of great current significance.

  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Information for Advertisers
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more